Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved 1. Sub-division of equity shares from face value of Rs.10/- each to face value of Rs.02/- each., 2. Alteration of Capital Clause of the Memorandum of Association of the Company Subsequent to Sub-Division of Equity Shares, 3. Increase in Authorized Share Capital and Consequent Alteration to the Capital Clause of the Memorandum of Association, 4. Issue of Bonus Shares in the ratio of 1:1.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anlon Healthcare's board, meeting on March 6, 2026, approved a sub-division (stock split) of equity shares from face value Rs.10 to Rs.2, turning each share into 5 shares. The company will also double its authorized share capital from Rs.55 crore to Rs.110 crore to accommodate further issuances. Additionally, the board approved a bonus issue in a 1:1 ratio, meaning every shareholder will receive one free share for every one held, resulting in roughly 2.66 crore new bonus shares of Rs.2 each. The bonus will be issued from free reserves of about Rs.147 crore available as on December 31, 2025. The record date for both the split and the bonus is yet to be announced, and shareholder approval will be sought via postal ballot.
The stock split should make shares more affordable and improve liquidity for retail investors, while the 1:1 bonus doubles the number of shares held without any cost — though the share price will adjust downward accordingly. Net wealth remains unchanged for existing shareholders on both actions, but higher share count and lower price typically improve trading activity.